The UK stock market’s often glossed over by foreign investors in favour of hyped-up US tech darlings. But that doesn’t reveal weakness, it’s just built differently. And for long-term, retirement-focused investors, that difference can be a real advantage.
While US indices chase the next AI moonshot, London-listed companies tend to focus on steady cash generation, dividends and buybacks. The result? Less drama, more dependability.
Here’s why I believe it trumps the ‘growth-at-any-cost’ mentality.
Hype fades, value endures
Hype is often just that: hype. And when it fades, value fades too. That’s a common US problem. Many stocks are high risk/high reward.
Just look at Super Micro Computer. The AI server specialist was the hottest stock on the market in early 2024, rising over 300% in the first few months of the year. By late 2024 and into 2025, the share price had fallen sharply from its peak, down around 60% at one point as questions surfaced over financial reporting and auditor changes.
By comparison, the UK offers resilience and reliability. Not fancy product launches and grandiose promises.
Yes, we do also have outliers, like Rolls-Royce. But in general, the UK stock market chugs along like a reliable commuter train (not a SpaceX rocket!).
For this reason, it offers steady income rather than price volatility. And that’s exactly the kind of thing long-term, retirement-focused investors should be looking for.
Take the following example.
The boring, brilliant company built to last
Diploma‘s (LSE:DPLM) the perfect example of a ‘boring’ UK stock that I plan to hold right into retirement. It sells specialised, essential products and components that businesses around the world need to keep operating.
Not just this week, not just next year, for decades ahead.
These are critical components, commanding premium pricing with limited competition. The company’s three divisions, Controls, Seals and Life Sciences, supply everything from industrial connectors and seals to surgical and scientific consumables.
FY2025 results showed revenue of £1.524bn, up 12%, earnings per share (EPS) of 176p, up 21%, and organic growth of 11%.
For FY2026, the company’s guided for 14% organic growth, with operating margins expected around 26.5%. That guidance was backed by strong nine-month trading, with growth already hitting 15% in the period up to June.
This is what dependable compounding looks like. No single blockbuster product, just lots of small operational wins building on one another.
